Myocardial fibrosis may precede clinical HFpEF diagnosis and is associated with disease severity, highlighting it as a potential therapeutic target.
No takes yet. Share an insight, caveat, or question.
May aid HFpEF risk stratification; leaves open whether fibrosis is a modifiable target.
Schelbert et al. (2017) studied this question.